A bioequivalence study of proposed bevacizumab biosimilar, MYL-1402O (A) vs EU-Avastin (B) and US-Avasting (C) Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Waller, C. F.; Socinski, M. A.; Hummel, M.; Bosje, T.; Shaw, A.; Liu, M. S.; Baczkowski, M.; Barve, A.; Kothekar, M.; Pennella, E. J.

authors

Publication Date

  • September 1, 2017

webpage

published in

category

start page

  • 163

end page

  • +

volume

  • 40